APO RESEARCH · REPORT
Intrauterine Devices
An intrauterine device (IUD) is a small contraceptive device that is put into the uterus (womb) to prevent pregnancy. The 2 types available in Australia are the copper IUD and the hormonal IUD (MirenaTM). The copper IUD is designed to stay in place for up to 10 years and the hormonal IUD (Mirena) for 5 years. Both can easily be removed sooner, if needed.
Product & engineering
Understand the product.
An intrauterine device (IUD) is a small contraceptive device that is put into the uterus (womb) to prevent pregnancy. The 2 types available in Australia are the copper IUD and the hormonal IUD (MirenaTM). The copper IUD is designed to stay in place for up to 10 years and the hormonal IUD (Mirena) for 5 years. Both can easily be removed sooner, if needed.
Selected research
Market Outlook & Growth Opportunities
Global Intrauterine Devices Market Outlook and Growth Opportunities 2026
Market perspective
An intrauterine device (IUD) is a small contraceptive device that is put into the uterus (womb) to prevent pregnancy. The 2 types available in Australia are the copper IUD and the hormonal IUD (MirenaTM). The copper IUD is designed to stay in place for up to 10 years and the hormonal IUD (Mirena) for 5 years. Both can easily be removed sooner, if needed.
Global core intrauterine devices manufacturers include Qualitrol, Mitsubishi Electric and Eaton etc. The top 1 company hold a share about 56%. North America is the largest market, with a share about 65%, followed by Europe and Asia Pacific with the share about 24% and 8%.
This report provides an overview of the global Intrauterine Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Intrauterine Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Intrauterine Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intrauterine Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Intrauterine Devices Segment by Company
Bayer
Merck
Teva Pharmaceutical
Allergan
HRA Pharma
Eurogine
Yantai JiShengYaoXie
TianYi
SMB Corporation
Shenyang Liren
H & J Medical
Cooper Companies
AbbVie Allergan
Intrauterine Devices Segment by Type
Hormonal IUD
Copper IUD
Intrauterine Devices Segment by End User
Age 20-24
Age 25-34
Age 35-44
Others
Intrauterine Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Intrauterine Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Intrauterine Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Intrauterine Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Intrauterine Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intrauterine Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intrauterine Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intrauterine Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Intrauterine Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intrauterine Devices industry.
Chapter 3: Detailed analysis of Intrauterine Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Intrauterine Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Intrauterine Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Hormonal IUD
- Copper IUD
Applications
- Age 20-24
- Age 25-34
- Age 35-44
- Others
Companies covered
- Bayer
- Merck
- Teva Pharmaceutical
- Allergan
- HRA Pharma
- Eurogine
- Yantai JiShengYaoXie
- TianYi
- SMB Corporation
- Shenyang Liren
- H & J Medical
- Cooper Companies
- AbbVie Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Intrauterine Devices Sales Value (2021-2032)
- 1.2.2 Global Intrauterine Devices Sales Volume (2021-2032)
- 1.2.3 Global Intrauterine Devices Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Intrauterine Devices Market Dynamics
- 2.1 Intrauterine Devices Industry Trends
- 2.2 Intrauterine Devices Industry Drivers
- 2.3 Intrauterine Devices Industry Opportunities and Challenges
- 2.4 Intrauterine Devices Industry Restraints
3 Intrauterine Devices Market by Company
- 3.1 Global Intrauterine Devices Company Revenue Ranking in 2025
- 3.2 Global Intrauterine Devices Revenue by Company (2021-2026)
- 3.3 Global Intrauterine Devices Sales Volume by Company (2021-2026)
- 3.4 Global Intrauterine Devices Average Price by Company (2021-2026)
- 3.5 Global Intrauterine Devices Company Ranking (2024-2026)
- 3.6 Global Intrauterine Devices Company Manufacturing Base and Headquarters
- 3.7 Global Intrauterine Devices Company Product Type and Application
- 3.8 Global Intrauterine Devices Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Intrauterine Devices Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Intrauterine Devices Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Intrauterine Devices Market by Type
- 4.1 Intrauterine Devices Type Introduction
- 4.1.1 Hormonal IUD
- 4.1.2 Copper IUD
- 4.2 Global Intrauterine Devices Sales Volume by Type
- 4.2.1 Global Intrauterine Devices Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Intrauterine Devices Sales Volume by Type (2021-2032)
- 4.2.3 Global Intrauterine Devices Sales Volume Share by Type (2021-2032)
- 4.3 Global Intrauterine Devices Sales Value by Type
- 4.3.1 Global Intrauterine Devices Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Intrauterine Devices Sales Value by Type (2021-2032)
- 4.3.3 Global Intrauterine Devices Sales Value Share by Type (2021-2032)
5 Intrauterine Devices Market by Application
- 5.1 Intrauterine Devices Application Introduction
- 5.1.1 Age 20-24
- 5.1.2 Age 25-34
- 5.1.3 Age 35-44
- 5.1.4 Others
- 5.2 Global Intrauterine Devices Sales Volume by Application
- 5.2.1 Global Intrauterine Devices Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Intrauterine Devices Sales Volume by Application (2021-2032)
- 5.2.3 Global Intrauterine Devices Sales Volume Share by Application (2021-2032)
- 5.3 Global Intrauterine Devices Sales Value by Application
- 5.3.1 Global Intrauterine Devices Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Intrauterine Devices Sales Value by Application (2021-2032)
- 5.3.3 Global Intrauterine Devices Sales Value Share by Application (2021-2032)
6 Intrauterine Devices Regional Sales and Value Analysis
- 6.1 Global Intrauterine Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Intrauterine Devices Sales by Region (2021-2032)
- 6.2.1 Global Intrauterine Devices Sales by Region: 2021-2026
- 6.2.2 Global Intrauterine Devices Sales by Region (2027-2032)
- 6.3 Global Intrauterine Devices Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Intrauterine Devices Sales Value by Region (2021-2032)
- 6.4.1 Global Intrauterine Devices Sales Value by Region: 2021-2026
- 6.4.2 Global Intrauterine Devices Sales Value by Region (2027-2032)
- 6.5 Global Intrauterine Devices Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Intrauterine Devices Sales Value (2021-2032)
- 6.6.2 North America Intrauterine Devices Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Intrauterine Devices Sales Value (2021-2032)
- 6.7.2 Europe Intrauterine Devices Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Intrauterine Devices Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Intrauterine Devices Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Intrauterine Devices Sales Value (2021-2032)
- 6.9.2 South America Intrauterine Devices Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Intrauterine Devices Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Intrauterine Devices Sales Value Share by Country, 2025 VS 2032
7 Intrauterine Devices Country-level Sales and Value Analysis
- 7.1 Global Intrauterine Devices Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Intrauterine Devices Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Intrauterine Devices Sales by Country (2021-2032)
- 7.3.1 Global Intrauterine Devices Sales by Country (2021-2026)
- 7.3.2 Global Intrauterine Devices Sales by Country (2027-2032)
- 7.4 Global Intrauterine Devices Sales Value by Country (2021-2032)
- 7.4.1 Global Intrauterine Devices Sales Value by Country (2021-2026)
- 7.4.2 Global Intrauterine Devices Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.9.2 France Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.16.2 China Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.19.2 India Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Intrauterine Devices Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Intrauterine Devices Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Intrauterine Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Bayer
- 8.1.1 Bayer Company Information
- 8.1.2 Bayer Business Overview
- 8.1.3 Bayer Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Bayer Intrauterine Devices Product Portfolio
- 8.1.5 Bayer Recent Developments
- 8.2 Merck
- 8.2.1 Merck Company Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Merck Intrauterine Devices Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 Teva Pharmaceutical
- 8.3.1 Teva Pharmaceutical Company Information
- 8.3.2 Teva Pharmaceutical Business Overview
- 8.3.3 Teva Pharmaceutical Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Teva Pharmaceutical Intrauterine Devices Product Portfolio
- 8.3.5 Teva Pharmaceutical Recent Developments
- 8.4 Allergan
- 8.4.1 Allergan Company Information
- 8.4.2 Allergan Business Overview
- 8.4.3 Allergan Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Allergan Intrauterine Devices Product Portfolio
- 8.4.5 Allergan Recent Developments
- 8.5 HRA Pharma
- 8.5.1 HRA Pharma Company Information
- 8.5.2 HRA Pharma Business Overview
- 8.5.3 HRA Pharma Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.5.4 HRA Pharma Intrauterine Devices Product Portfolio
- 8.5.5 HRA Pharma Recent Developments
- 8.6 Eurogine
- 8.6.1 Eurogine Company Information
- 8.6.2 Eurogine Business Overview
- 8.6.3 Eurogine Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Eurogine Intrauterine Devices Product Portfolio
- 8.6.5 Eurogine Recent Developments
- 8.7 Yantai JiShengYaoXie
- 8.7.1 Yantai JiShengYaoXie Company Information
- 8.7.2 Yantai JiShengYaoXie Business Overview
- 8.7.3 Yantai JiShengYaoXie Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Yantai JiShengYaoXie Intrauterine Devices Product Portfolio
- 8.7.5 Yantai JiShengYaoXie Recent Developments
- 8.8 TianYi
- 8.8.1 TianYi Company Information
- 8.8.2 TianYi Business Overview
- 8.8.3 TianYi Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.8.4 TianYi Intrauterine Devices Product Portfolio
- 8.8.5 TianYi Recent Developments
- 8.9 SMB Corporation
- 8.9.1 SMB Corporation Company Information
- 8.9.2 SMB Corporation Business Overview
- 8.9.3 SMB Corporation Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.9.4 SMB Corporation Intrauterine Devices Product Portfolio
- 8.9.5 SMB Corporation Recent Developments
- 8.10 Shenyang Liren
- 8.10.1 Shenyang Liren Company Information
- 8.10.2 Shenyang Liren Business Overview
- 8.10.3 Shenyang Liren Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Shenyang Liren Intrauterine Devices Product Portfolio
- 8.10.5 Shenyang Liren Recent Developments
- 8.11 H & J Medical
- 8.11.1 H & J Medical Company Information
- 8.11.2 H & J Medical Business Overview
- 8.11.3 H & J Medical Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.11.4 H & J Medical Intrauterine Devices Product Portfolio
- 8.11.5 H & J Medical Recent Developments
- 8.12 Cooper Companies
- 8.12.1 Cooper Companies Company Information
- 8.12.2 Cooper Companies Business Overview
- 8.12.3 Cooper Companies Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Cooper Companies Intrauterine Devices Product Portfolio
- 8.12.5 Cooper Companies Recent Developments
- 8.13 AbbVie Allergan
- 8.13.1 AbbVie Allergan Company Information
- 8.13.2 AbbVie Allergan Business Overview
- 8.13.3 AbbVie Allergan Intrauterine Devices Sales, Value and Gross Margin (2021-2026)
- 8.13.4 AbbVie Allergan Intrauterine Devices Product Portfolio
- 8.13.5 AbbVie Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Intrauterine Devices Value Chain Analysis
- 9.1.1 Intrauterine Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Intrauterine Devices Sales Mode & Process
- 9.2 Intrauterine Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Intrauterine Devices Distributors
- 9.2.3 Intrauterine Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst